Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
44,5 USD | -0,55% | -4,82% | +62,11% |
07/03 | MERUS N.V. : Needham & Co. herhaalt koopadvies | ZM |
06/03 | Gilead Sciences, Merus werken samen om nieuwe potentiële kankertherapieën te ontdekken | MT |
Omzet 2024 * | 36,24 mln. 33,59 mln. | Omzet 2025 * | 49,19 mln. 45,59 mln. | Marktkapitalisatie | 2,61 mld. 2,42 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -191 mln. -177 mln. | Nettowinst (verlies) 2025 * | -223 mln. -207 mln. | EV/omzet 2024 * | 72 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 53,1 x |
K/w-verhouding 2024 * |
-14,1
x | K/w-verhouding 2025 * |
-13,3
x | Werknemers | 201 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,77% |
1 dag | -0,36% | ||
1 week | -1,32% | ||
Lopende maand | -7,69% | ||
1 maand | -8,56% | ||
3 maanden | +56,63% | ||
6 maanden | +85,76% | ||
Lopend jaar | +62,73% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bill Lundberg
CEO | Chief Executive Officer | 60 | 12-06-19 |
Gregory Perry
DFI | Director of Finance/CFO | 63 | 01-05-16 |
Chief Tech/Sci/R&D Officer | - | 01-12-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gregory Perry
DFI | Director of Finance/CFO | 63 | 01-05-16 |
Maxine Gowen
BRD | Director/Board Member | 66 | 28-05-21 |
Paolo Pucci
BRD | Director/Board Member | 63 | 30-06-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.11% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0,00% | - | |
0.06% | 0 M€ | 0,00% | - | |
0.04% | 7 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 44,58 | -0,37% | 104 389 |
27-03-24 | 44,75 | -0,36% | 234 581 |
26-03-24 | 44,91 | +0,34% | 304 072 |
25-03-24 | 44,76 | -2,55% | 311 163 |
22-03-24 | 45,93 | -1,94% | 697 288 |
uitgestelde koers Nasdaq, 27 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+62,73% | 2,61 mld. | |
+2,56% | 108 mld. | |
+10,02% | 104 mld. | |
+7,48% | 23,66 mld. | |
-11,91% | 22,1 mld. | |
-3,29% | 19,71 mld. | |
-35,98% | 18,2 mld. | |
-14,02% | 16,19 mld. | |
+4,61% | 13,72 mld. | |
+35,05% | 12,22 mld. |